“Global Advanced Wound Care Market is expected to grow at 7.6% in the forecast period 2017 to 2024”
Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography – Industry Trends and Forecast to 2024
Global Advanced Wound Care Market is expected to reach USD 20.7 billion by 2024, from USD 11.6 billion in 2016 growing at a CAGR of 7.6% during the forecast period of 2017 to 2024.
Global Advanced Wound Care Market is segmented based on type, product type, application, end-user, distribution channel and geography.
For Sample Report: Global Advanced Wound Care Market – Industry Trends and Forecast to 2024
On the basis of type the advanced wound care market is segmented into dressings, biologics and therapy devices.
To read more about the scope and findings of this report visit: Global Topical Drug Delivery Market is poised to grow at 9.2% till 2024
Based on product type the market is further segmented into foam dressings, film dressings, hydrogels, alginates, wound contact layers and super absorbent dressings. The advanced wound care biologics market segment is sub-segment into allografts, synthetic skin grafts, xenografts, and growth factors. The Therapy devices segment is further classified on the basis of product type into NPWT devices, pressure relief devices, hyperbaric oxygen chambers (HBOT), wound debridement.
On the basis of application the advanced wound care devices market is segmented into surgical wounds, diabetic ulcers, pressure ulcers, venous ulcers, burns and others.
Based on end-user the market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.
KEY PLAYERS OPERATING IN GLOBAL ADVANCED WOUND CARE MARKET:
3M
Smith and Nephew
Medtronic
Acelity L.P., Inc.
Becton Dickinson and Company
Molyncke Healthcare AB
Convatec, Inc.
Baxter
Coloplast
Ethicon, Inc.
Hollister Incorporated
Integra Lifesciences Corporation
Derma Sciences, Inc.
Spiracur, Inc.
Medline Industries
Mimedx, Inc.
Organogenesis, Inc.
Talley Group
BSN Medical
Devon Medical Products
Human Biosciences, Inc.
Cardinal Health
B.Braun Melsungen AG
Paul Hartmann Limited
To Browse Full Report and Pricing: Global Advanced Wound Care Market – Industry Trends and Forecast to 2024
Table of Content:
1 INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL ADVANCED WOUND CARE MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL ADVANCED WOUND CARE MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL ADVANCED WOUND CARE MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL ADVANCED WOUND CARE MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. INCREASING ACCEPTANCE OF WOUND CARE BIOLOGICS
4.3.1.2. TECHNOLOGICALLY BENEFICIAL
4.3.1.3. INCREASING POOL OF AGING POPULATION AND DIABETES
4.3.1.4. INCREASING DEMAND FOR MODERN HEALTHCARE IN ASIA
4.3.1.5. RISING ACCEPTANCE OF HOME HEALTHCARE
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 ADVANCED WOUND CARE MARKET, BY TYPE
5.1. OVERVIEW
5.2. ADVANCED WOUND CARE DRESSINGS, BY PRODUCT TYPE
5.2.1. FILM DRESSINGS
5.2.2. FOAM DRESSINGS
5.2.3. HYDROGELS
5.2.4. ALGINATES
5.2.5. WOUND CONTACT LAYERS
5.2.6. SUPER ABSORBENT DRESSINGS
5.3. ADVANCED WOUND CARE BIOLOGICS, BY PRODUCT TYPE
5.3.1. ALLOGRAFTS
5.3.2. SYNTHETIC SKIN GRAFTS
5.3.3. XENOGRAFTS
5.3.4. GROWTH FACTORS
5.3.4.1. PLATELET-DERIVED GROWTH FACTOR (PDGF)
5.3.4.2. PLATELET RICH PLASMA (PRP)
5.3.4.3. EPIDERMAL GROWTH FACTORS (EGF)
5.3.4.4. BASIC FIBROBLAST GROWTH FACTOR (BFGF)
5.3.4.5. GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF)
5.3.4.6. TALACTOFERRIN ALFA
5.3.4.7. THROMBIN PEPTIDE (TP508)
5.3.4.8. KERATINOCYTE GROWTH FACTOR (KGF)
5.4. ADVANCED WOUND CARE THERAPY DEVICES, BY PRODUCT TYPE
5.4.1. NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
5.4.1.1. STAND-ALONE NPWT DEVICES
5.4.1.2. PORTABLE NPWT DEVICES
5.4.1.3. DISPOSABLE NPWT DEVICES
5.4.2. PRESSURE RELIEF DEVICES (PRD)
5.4.2.1. MATRESSES
5.4.2.2. BEDS
5.4.3. HYBERBARIC OXYGEN CHAMBERS
5.4.3.1. MONOPLACE
5.4.3.2. MULTIPLACE
5.4.3.3. TOPICAL
5.4.4. WOUND DEBRIDEMENT DEVICES
5.4.4.1. HYDROSURGICAL
5.4.4.2. MECHANICAL
5.4.4.3. ULTRASOUND
5.4.4.4. OTHERS
5.4.5. PHYSICAL THERAPIES
5.4.5.1. LASER THERAPY
5.4.5.2. ELECTRICAL STIMULATION
5.4.5.3. EXTERNAL SHOCK WAVE THERAPIES (ESWT)
5.4.5.4. SALINE MIST THERAPY
6 ADVANCED WOUND CARE MARKET, BY WOUND TYPE
6.1. OVERVIEW
6.2. SURGICAL WOUNDS
6.3. DIABETIC ULCERS
6.4. PRESSURE ULCERS
6.5. VENOUS ULCERS
6.6. BURNS
6.7. OTHERS
7 ADVANCED WOUND CARE MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. WOUND CARE CENTERS
7.4. AMBULATORY CENTERS
7.5. HOME HEALTHCARE
7.6. CLINICS
7.6. COMMUNITY HEALTHCARE
8 ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DIRECT TENDERS
8.3. RETAIL
9 ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE ADVANCED WOUND CARE MARKET,
(ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY
COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10 ADVANCED WOUND CARE MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.4. APAC ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.6. MEA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11 ADVANCED WOUND CARE MARKET, COMPANY PROFILES
11.1 3M
11.1.1 COMPANY OVERVIEW
11.1.2 SWOT ANALYSIS
11.1.3 REVENUE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPEMENTS
11.1.6 DATA BRIDGE ANALYSIS
11.2 SMITH AND NEPHEW
11.2.1 COMPANY OVERVIEW
11.2.2 SWOT ANALYSIS
11.2.3 REVENUE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPEMENTS
11.2.6 DATA BRIDGE ANALYSIS
11.3 MEDTRONIC
11.3.1 COMPANY OVERVIEW
11.3.2 SWOT ANALYSIS
11.3.3 REVENUE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPEMENTS
11.3.6 DATA BRIDGE ANALYSIS
11.4 ACELITY L.P. INC.
11.4.1 COMPANY OVERVIEW
11.4.2 SWOT ANALYSIS
11.4.3 REVENUE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPEMENTS
11.4.6 DATA BRIDGE ANALYSIS
11.5 BECTON, DICKINSON AND COMPANY
11.5.1 COMPANY OVERVIEW
11.5.2 SWOT ANALYSIS
11.5.3 REVENUE ANALYSIS
11.5.4 PRODUCT PORTFOLIO
11.5.5 RECENT DEVELOPEMENTS
11.5.6 DATA BRIDGE ANALYSIS
11.6 MOLYNCKE HEALTH CARE AB
11.6.1 COMPANY OVERVIEW
11.6.2 SWOT ANALYSIS
11.6.3 REVENUE ANALYSIS
11.6.4 PRODUCT PORTFOLIO
11.6.5 RECENT DEVELOPEMENTS
11.6.6 DATA BRIDGE ANALYSIS
11.7 CONVATEC INC.
11.7.1 COMPANY OVERVIEW
11.7.2 SWOT ANALYSIS
11.7.3 REVENUE ANALYSIS
11.7.4 PRODUCT PORTFOLIO
11.7.5 RECENT DEVELOPEMENTS
11.7.5 DATA BRIDGE ANALYSIS
11.8 BAXTER
11.8.1 COMPANY OVERVIEW
11.8.2 SWOT ANALYSIS
11.8.3 REVENUE ANALYSIS
11.8.4 PRODUCT PORTFOLIO
11.8.5 RECENT DEVELOPEMENTS
11.8.6 DATA BRIDGE ANALYSIS
11.9 COLOPLAST
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.6 DATA BRIDGE ANALYSIS
11.10 ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
11.10.1 COMPANY OVERVIEW
11.10.2 SWOT ANALYSIS
11.10.3 REVENUE ANALYSIS
11.10.4 PRODUCT PORTFOLIO
11.10.5 RECENT DEVELOPEMENTS
11.10.5 DATA BRIDGE ANALYSIS
11.11 HOLLISTER INCORPORATED
11.11.1 COMPANY OVERVIEW
11.11.2 SWOT ANALYSIS
11.11.3 REVENUE ANALYSIS
11.11.4 PRODUCT PORTFOLIO
11.11.5 RECENT DEVELOPEMENTS
11.11.5 DATA BRIDGE ANALYSIS
11.12 INTEGRA LIFESCIENCES CORPORATION
11.12.1 COMPANY OVERVIEW
11.12.2 SWOT ANALYSIS
11.12.3 REVENUE ANALYSIS
11.12.4 PRODUCT PORTFOLIO
11.12.5 RECENT DEVELOPEMENTS
11.12.5 DATA BRIDGE ANALYSIS
11.13 DERMA SCIENCES INC.
11.13.1 COMPANY OVERVIEW
11.13.2 SWOT ANALYSIS
11.13.3 REVENUE ANALYSIS
11.13.4 PRODUCT PORTFOLIO
11.13.5 RECENT DEVELOPEMENTS
11.13.5 DATA BRIDGE ANALYSIS
11.14 SPIRACUR, INC.
11.14.1 COMPANY OVERVIEW
11.14.2 SWOT ANALYSIS
11.14.3 REVENUE ANALYSIS
11.14.4 PRODUCT PORTFOLIO
11.14.5 RECENT DEVELOPEMENTS
11.14.5 DATA BRIDGE ANALYSIS
11.15 MEDLINE INDUSTRIES
11.15.1 COMPANY OVERVIEW
11.15.2 SWOT ANALYSIS
11.15.3 REVENUE ANALYSIS
11.15.4 PRODUCT PORTFOLIO
11.15.5 RECENT DEVELOPEMENTS
11.15.5 DATA BRIDGE ANALYSIS
11.16 MIMEDX GROUP
11.16.1 COMPANY OVERVIEW
11.16.2 SWOT ANALYSIS
11.16.3 REVENUE ANALYSIS
11.16.4 PRODUCT PORTFOLIO
11.16.5 RECENT DEVELOPEMENTS
11.16.5 DATA BRIDGE ANALYSIS
11.17 ORGANOGENESIS, INC.
11.17.1 COMPANY OVERVIEW
11.17.2 SWOT ANALYSIS
11.17.3 REVENUE ANALYSIS
11.17.4 PRODUCT PORTFOLIO
11.17.5 RECENT DEVELOPEMENTS
11.17.5 DATA BRIDGE ANALYSIS
11.18 TALLEY GROUP
11.18.1 COMPANY OVERVIEW
11.18.2 SWOT ANALYSIS
11.18.3 REVENUE ANALYSIS
11.18.4 PRODUCT PORTFOLIO
11.18.5 RECENT DEVELOPEMENTS
11.18.5 DATA BRIDGE ANALYSIS
11.19 BSN MEDICAL
11.19.1 COMPANY OVERVIEW
11.19.2 SWOT ANALYSIS
11.19.3 REVENUE ANALYSIS
11.19.4 PRODUCT PORTFOLIO
11.19.5 RECENT DEVELOPEMENTS
11.19.5 DATA BRIDGE ANALYSIS
11.20 DEVON MEDICAL PRODUCTS
11.20.1 COMPANY OVERVIEW
11.20.2 SWOT ANALYSIS
11.20.3 REVENUE ANALYSIS
11.20.4 PRODUCT PORTFOLIO
11.20.5 RECENT DEVELOPEMENTS
11.20.5 DATA BRIDGE ANALYSIS
11.21 HUMAN BIOSCIENCES, INC.
11.21.1 COMPANY OVERVIEW
11.21.2 SWOT ANALYSIS
11.21.3 REVENUE ANALYSIS
11.21.4 PRODUCT PORTFOLIO
11.21.5 RECENT DEVELOPEMENTS
11.21.5 DATA BRIDGE ANALYSIS
11.22 B.BRAUN MELSUNGEN AG
11.22.1 COMPANY OVERVIEW
11.22.2 SWOT ANALYSIS
11.22.3 REVENUE ANALYSIS
11.22.4 PRODUCT PORTFOLIO
11.22.5 RECENT DEVELOPEMENTS
11.22.5 DATA BRIDGE ANALYSIS
11.23 CARDINAL HEALTH
11.23.1 COMPANY OVERVIEW
11.23.2 SWOT ANALYSIS
11.23.3 REVENUE ANALYSIS
11.23.4 PRODUCT PORTFOLIO
11.23.5 RECENT DEVELOPEMENTS
11.23.5 DATA BRIDGE ANALYSIS
11.24 PAUL HARTMANN LIMITED
11.24.1 COMPANY OVERVIEW
11.24.2 SWOT ANALYSIS
11.24.3 REVENUE ANALYSIS
11.24.4 PRODUCT PORTFOLIO
11.24.5 RECENT DEVELOPEMENTS
11.24.5 DATA BRIDGE ANALYSIS
12 APPENDIX
12.1. EPIDEMIOLOGY DATA
12.2. SOURCES AND BIBLIOGRAPHY
12.3. RELATED REPORTS
12.4. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK
13 ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports:
North America Advanced Wound Care Market – Trends and Forecast to 2022
By Product Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Surgical Centers, Other Healthcare Providers), By Geography (U.S., Canada, Mexico) – Trends and Forecast to 2022
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-advanced-wound-care-market/